Bridgepoint Development Capital Recapitalizes Prescient Healthcare Group
January 21, 2021
Bridgepoint Development Capital led a recapitalization of Prescient Healthcare Group, a London-based product strategy consultancy serving the global biopharmaceutical industry; the transaction closed January 19, 2021. Baird Capital (the exiting majority investor) provided a full exit but reinvested as a minority shareholder alongside Bridgepoint to support Prescient's next phase of growth and international expansion.
- Targets
- Prescient Healthcare Group
- Sellers
- Baird Capital
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Prescient Healthcare Group Acquires Dolon
April 1, 2026
Healthcare Services
Prescient Healthcare Group has acquired Dolon, a London-based consultancy specializing in strategic pricing and market access for biopharma. The deal is intended to expand Prescient’s value, pricing, and access capabilities across the drug lifecycle, supported by Prescient’s investor Bridgepoint.
-
Prescient Healthcare Group Acquires Uptake
January 9, 2026
Healthcare Services
Prescient Healthcare Group has acquired Uptake (Uptake Strategies Ltd), a global healthcare consultancy, to strengthen Prescient’s commercial practice and expand capabilities for pharmaceutical and biotech clients. The deal is supported by Prescient’s existing investor Bridgepoint Development Capital; Uptake’s CEO Stephanie Hall will join Prescient’s board and lead the combined Commercial Practice during integration.
-
Align Capital Partners Recapitalizes Premier Biotech
December 7, 2022
Medical Devices
Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.
-
Prescient Acquires Strategic North
March 2, 2022
Consulting
Prescient, a PE-backed biopharma product and portfolio strategy consultancy, has acquired Strategic North, a UK-based commercial strategy and brand research consultancy serving pharmaceutical and biotech clients. The acquisition is an add-on to Prescient’s platform intended to deepen its commercial and brand strategy capabilities for global pharma and biotech customers.
-
Charlesbank Capital Partners Makes Growth Investment in Bridgepointe Technologies
January 11, 2022
IT Services
Charlesbank Capital Partners has made a strategic growth investment in Bridgepointe Technologies, a San Mateo-based IT strategy and advisory firm. Bridgepointe raised more than $100 million in total proceeds to fund partner recruitment and enablement, service and brand expansion, key hires, and future acquisitions.
-
Brentwood Associates Recapitalizes MedBridge
January 13, 2021
Healthcare Services
Brentwood Associates has recapitalized MedBridge, a SaaS provider of patient engagement and clinical education solutions, with LLR Partners and senior management retaining significant minority stakes. The investment will fund continued organic growth, support future acquisitions, and enable expansion into additional healthcare specialties and care settings.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.